日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis

生物制剂在初治和经治银屑病患者中的药物生存率

Schwarz, Christopher Willy; Loft, Nikolai; Bryld, Lars Erik; Nissen, Christoffer Valdemar; Ajgeiy, Kawa Khaled; Bertelsen, Trine; Hjuler, Kasper Fjellhaugen; Dam, Tomas Norman; Iversen, Lars; Rasmussen, Mads Kirchheiner; Skov, Lone

Real-world Drug Survival of Biosimilar SB5 vs GP2017 Following a Mandatory Non-medical Switch from Adalimumab Originator for Psoriasis: A Nationwide Cohort Study

银屑病患者在强制非医疗原因转换至生物类似药 SB5 和 GP2017 后,其真实世界药物生存率的比较:一项全国性队列研究

Sieborg, Johan; Maul, Julia-Tatjana; Wu, Jashin J; Loft, Nikolai Nguyen; Skov, Lone; Bryld, Lars Erik; Rasmussen, Mads Kirchheiner; Dam, Tomas Norman; Bertelsen, Trine; Ajgeiy, Kawa Khaled; Thomsen, Simon Francis; Thyssen, Jacob P; Egeberg, Alexander; Thein, David

Training load and pain response during progressive resistance training in patients with hip osteoarthritis in the PROHIP trial

PROHIP试验中髋关节骨关节炎患者渐进阻力训练期间的训练负荷和疼痛反应

Bryld, Emma Smed; Christiansen, Laura; Ingwersen, Kim Gordon; Overgaard, Søren; Mikkelsen, Lone Ramer; Mechlenburg, Inger; Frydendal, Thomas

Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study

根据既往生物制剂暴露情况对白细胞介素-17A抑制剂的反应:一项丹麦全国性研究

Loft, Nikolai; Egeberg, Alexander; Isufi, Daniel; Rasmussen, Mads K; Bryld, Lars E; Dam, Tomas N; Ajgeiy, Kawa K; Bertelsen, Trine; Skov, Lone

Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With Psoriasis

银屑病患者从阿达木单抗原研药强制非医疗原因转换为阿达木单抗生物类似药后的结果

Loft, Nikolai; Egeberg, Alexander; Rasmussen, Mads Kirchheiner; Bryld, Lars Erik; Nissen, Christoffer Valdemar; Dam, Tomas Norman; Ajgeiy, Kawa Khaled; Iversen, Lars; Skov, Lone

Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide Study

一项丹麦全国性研究表明,在未接受过生物制剂治疗的银屑病患者中,治疗前六个月对生物制剂的反应可预测疾病复发的风险:

Loft, Nikolai; Egeberg, Alexander; Rasmussen, Mads Kirchheiner; Bryld, Lars Erik; Nissen, Christoffer V; Dam, Tomas Norman; Ajgeiy, Kawa Khaled; Iversen, Lars; Skov, Lone